AIA Group Ltd Has $201,000 Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

AIA Group Ltd boosted its stake in Henry Schein, Inc. (NASDAQ:HSICGet Rating) by 32.9% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,304 shares of the company’s stock after purchasing an additional 571 shares during the quarter. AIA Group Ltd’s holdings in Henry Schein were worth $201,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of HSIC. Pendal Group Ltd grew its holdings in Henry Schein by 132.6% in the first quarter. Pendal Group Ltd now owns 3,111,253 shares of the company’s stock worth $271,271,000 after purchasing an additional 1,773,481 shares during the period. Alberta Investment Management Corp grew its holdings in Henry Schein by 1,349.8% in the fourth quarter. Alberta Investment Management Corp now owns 580,982 shares of the company’s stock worth $45,044,000 after purchasing an additional 540,908 shares during the period. JPMorgan Chase & Co. grew its holdings in Henry Schein by 8.5% in the fourth quarter. JPMorgan Chase & Co. now owns 2,678,838 shares of the company’s stock worth $207,690,000 after purchasing an additional 209,220 shares during the period. Woodline Partners LP grew its holdings in Henry Schein by 47.0% in the fourth quarter. Woodline Partners LP now owns 629,815 shares of the company’s stock worth $48,830,000 after purchasing an additional 201,318 shares during the period. Finally, Qube Research & Technologies Ltd acquired a new position in shares of Henry Schein during the fourth quarter valued at about $11,912,000. 94.30% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Henry Schein

In other Henry Schein news, EVP Gerald A. Benjamin sold 11,489 shares of the stock in a transaction on Thursday, May 26th. The stock was sold at an average price of $85.47, for a total transaction of $981,964.83. Following the completion of the transaction, the executive vice president now directly owns 95,616 shares of the company’s stock, valued at $8,172,299.52. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 1.00% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several equities analysts recently weighed in on HSIC shares. StockNews.com cut shares of Henry Schein from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, July 19th. Stifel Nicolaus lowered their price objective on Henry Schein from $90.00 to $80.00 in a research note on Friday, June 17th. Piper Sandler lowered their price objective on Henry Schein from $100.00 to $96.00 in a research note on Tuesday. William Blair reissued a “market perform” rating on shares of Henry Schein in a research note on Tuesday, May 3rd. Finally, Credit Suisse Group lowered their price objective on Henry Schein from $100.00 to $90.00 and set an “outperform” rating for the company in a research note on Wednesday. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $87.14.

Henry Schein Stock Performance

Shares of HSIC opened at $75.38 on Friday. The company has a current ratio of 1.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.18. The company has a market capitalization of $10.26 billion, a price-to-earnings ratio of 16.18, a PEG ratio of 2.00 and a beta of 0.75. The stock has a 50 day moving average of $77.98 and a 200 day moving average of $81.97. Henry Schein, Inc. has a 12 month low of $70.25 and a 12 month high of $92.68.

Henry Schein (NASDAQ:HSICGet Rating) last issued its quarterly earnings results on Tuesday, August 2nd. The company reported $1.16 EPS for the quarter, meeting analysts’ consensus estimates of $1.16. The company had revenue of $3.03 billion during the quarter, compared to the consensus estimate of $3.12 billion. Henry Schein had a return on equity of 15.56% and a net margin of 5.11%. Henry Schein’s revenue was up 2.1% on a year-over-year basis. During the same period last year, the business posted $1.11 earnings per share. As a group, sell-side analysts forecast that Henry Schein, Inc. will post 4.85 earnings per share for the current year.

Henry Schein Profile

(Get Rating)

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

See Also

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.